Orgenesis, a developer, manufacturer and service provider of advanced cell therapies, said that its subsidiary, Masthercell Global, is expanding into the U.S. and has executed a lease agreement to build a new 30,000 square foot manufacturing facility in Houston, TX. Masthercell Global is a cell and gene therapy contract development and manufacturing organization (CDMO) that will now have operations and manufacturing facilities across three continents—North America, Europe and Asia.   The compa...